Supporting Families Through Newborn Screening: Resources and Education

https://www.marketsandmarkets.com/Market-Reports/newborn-screening-market-141676244.html

The global newborn screening market size is projected to reach USD 1.3 billion by 2026 from USD 0.9 billion in 2021, at a CAGR of 8.3% during the forecast period. Market growth is driven mainly by the increasing prevalence of newborn diseases, government newborn screening prograsms and legislations, and availability of insurnace for newborn screening. However, the availability of refurbhieshed product is expected to hamper the sales of newborn screening market to a certain extents. On the other hand, emerging economies provides lucrative opportunites to the players operating in the newborn screening market.

The newborn screening market is highly consolidated in nature, with a few players offering a variety of products. The major players operating in this market are PerkinElmer (US), Deant A/S (Denmark), Natus Medical (US), Danaher Corporation (US), Masimo (US), Medtronic, Plc (Ireland). Other companies include Bio-Rad Laboratories (US), Trivitron Healthcare (India), Baebies, Inc (US), and Intelligent Hearing Systems Corp (US).